{"meta":{"query_hash":"ead79cb73d79","filters":{"venue":"Immunotherapy Advances"},"cohort_total":7,"direct_labels_cover":0,"predictions_cover":7,"exported":7,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ead79cb73d79","api":"https://metacan.xera.ac/api/v1/cohort?venue=Immunotherapy+Advances"},"results":[{"id":"W3215895013","doi":"10.1093/immadv/ltab022","title":"A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes","year":2021,"lang":"en","type":"article","venue":"Immunotherapy Advances","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; University of Calgary","funders":"Breakthrough T1D Canada; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Versus Arthritis; Diabetes UK; Leona M. and Harry B. Helmsley Charitable Trust; National Institute for Health and Care Research; Immune Tolerance Network; Innovative Medicines Initiative; BC Children's Hospital","keywords":"Medicine; Dosing; Internal medicine; Cohort; Maintenance therapy; Type 1 diabetes; Adverse effect; Type 2 diabetes; Clinical endpoint; Cmax; Gastroenterology; Immunology; Diabetes mellitus; Pharmacokinetics; Endocrinology; Randomized controlled trial; Chemotherapy","score_opus":0.01257137853055862,"score_gpt":0.3053642460621322,"score_spread":0.2927928675315736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215895013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421364,0.00084350887,0.00044267066,0.00019219423,0.000056858466,0.0030282612,0.00059261307,0.00003688936,0.00059334084],"genre_scores_gemma":[0.9908635,0.0007190766,0.0022148401,0.0008226246,0.000141825,0.003368135,0.00074132794,0.000016602107,0.0011119978],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990119,0.00056549633,0.00006225892,0.00014005121,0.00011162278,0.00010873693],"domain_scores_gemma":[0.9986634,0.00025991647,0.00033082397,0.00011781703,0.00013955832,0.00048851414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028012174,0.0009923928,0.0014040164,0.00033065164,0.0005495159,0.000612493,0.00058089616,0.0009947584,0.0029813473],"category_scores_gemma":[0.0018617671,0.000521557,0.00087687024,0.00028733144,0.0007204665,0.000765253,0.00035086097,0.0018375261,0.000706516],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7201509,0.1160774,0.03859989,0.00089570164,0.0015226208,0.0003070973,0.0006647421,0.00075205025,0.042695526,0.000116675605,0.0021691562,0.07604821],"study_design_scores_gemma":[0.42101026,0.52104473,0.051290143,0.00003908709,0.0006315292,0.0002602117,0.00011609796,0.00055063545,0.0025292493,0.0001128116,0.0023869055,0.000028285294],"about_ca_topic_score_codex":0.00084252027,"about_ca_topic_score_gemma":0.0026109433,"teacher_disagreement_score":0.0029813473,"about_ca_system_score_codex":0.0006603147,"about_ca_system_score_gemma":0.0016222277,"threshold_uncertainty_score":0.014814496},"labels":[],"label_agreement":null},{"id":"W4408363348","doi":"10.1093/immadv/ltaf006","title":"Development and evaluation of two whole-blood flow cytometry protocols for monitoring patients treated with JAK inhibitors","year":2024,"lang":"en","type":"article","venue":"Immunotherapy Advances","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Takeda Canada","keywords":"Flow cytometry; Phosphorylation; STAT5; Cytokine; stat; Biology; Immunology; STAT3; Molecular biology; Cell biology; Cancer research","score_opus":0.039189128658499606,"score_gpt":0.3721557140798626,"score_spread":0.332966585421363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408363348","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70657974,0.004068565,0.26115733,0.0012409536,0.0008216083,0.008763583,0.0055020656,0.0029882165,0.008877945],"genre_scores_gemma":[0.7967606,0.0012923465,0.17803349,0.0013088385,0.00031594245,0.011668298,0.0058120494,0.00020798967,0.004600451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956819,0.0013020718,0.00047186975,0.0009152953,0.0013658027,0.00026314476],"domain_scores_gemma":[0.9976191,0.00057890784,0.00048474845,0.0002857524,0.000841959,0.0001894938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040261517,0.0010859469,0.00082043884,0.0016518516,0.0005334345,0.0012249465,0.0011722624,0.001192108,0.003742852],"category_scores_gemma":[0.004121447,0.00042723276,0.00040154497,0.00072112767,0.0004813872,0.000627691,0.00056143565,0.0011607934,0.0014260284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008807024,0.0018507352,0.07014023,0.0007182348,0.00023576338,0.00029042884,0.0006846856,0.002463531,0.7650863,0.0015729697,0.0067737713,0.14137635],"study_design_scores_gemma":[0.0007927573,0.009888858,0.12146135,0.00019523813,0.00031912368,0.0017026968,0.00029069209,0.025843237,0.8184263,0.00101038,0.01992337,0.00014591985],"about_ca_topic_score_codex":0.00048362592,"about_ca_topic_score_gemma":0.0004783091,"teacher_disagreement_score":0.0040261517,"about_ca_system_score_codex":0.0006283314,"about_ca_system_score_gemma":0.0007534386,"threshold_uncertainty_score":0.021292567},"labels":[],"label_agreement":null},{"id":"W4408970497","doi":"10.1093/immadv/ltaf010","title":"Abnormal glucose and lipid metabolism promotes disrupted differentiation of T and B cell subsets in Behçet’s disease","year":2024,"lang":"en","type":"article","venue":"Immunotherapy Advances","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Natural Science Foundation of Shandong Province; National Natural Science Foundation of China","keywords":"Immune system; Immune dysregulation; Immunology; CD8; T cell; Dendritic cell; Flow cytometry; Biology; Pathogenesis; Cytotoxic T cell; In vitro","score_opus":0.0065555307667504534,"score_gpt":0.26065858318566415,"score_spread":0.2541030524189137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408970497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957819,0.0029204052,0.00046082126,0.00008191889,0.000010679994,0.0000069690445,0.00017250255,0.000015108392,0.00054971734],"genre_scores_gemma":[0.998218,0.0008918936,0.00041885776,0.00006700976,0.000015901147,0.0000056070853,0.0001506462,0.0000024252215,0.00022957203],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989426,0.000025192518,0.000012160414,0.000021337753,0.000023338367,0.000023732493],"domain_scores_gemma":[0.99993527,0.00001329936,0.000023690862,0.0000042663387,0.000009188157,0.00001430631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018583571,0.0002577109,0.000200345,0.00069439516,0.00018260743,0.000415034,0.000071594666,0.00020141415,0.0012483133],"category_scores_gemma":[0.00019312881,0.000099674595,0.00012874266,0.00035077851,0.00020824891,0.00014970316,0.00022367194,0.00024753076,0.00013220034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036370056,0.00012922347,0.29621986,0.000339179,0.00012665035,0.0033568512,0.00039798123,0.0003918003,0.63882965,0.00061426,0.0008270309,0.055130534],"study_design_scores_gemma":[0.00010067748,0.0006301338,0.88643694,0.000097397446,0.00015162838,0.009880085,0.00070340233,0.00169856,0.092190675,0.0013455276,0.0067413473,0.000023720953],"about_ca_topic_score_codex":0.0006373698,"about_ca_topic_score_gemma":0.0006389594,"teacher_disagreement_score":0.0012483133,"about_ca_system_score_codex":0.00021636699,"about_ca_system_score_gemma":0.00013982554,"threshold_uncertainty_score":0.004175961},"labels":[],"label_agreement":null},{"id":"W4413772343","doi":"10.1093/immadv/ltaf029","title":"CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis","year":2024,"lang":"en","type":"article","venue":"Immunotherapy Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; University of Southampton; Cancer Research UK; Leukaemia UK; National Institute for Health and Care Research; Wessex Medical Research","keywords":"Antibody-dependent cell-mediated cytotoxicity; Interleukin 15; Immunology; Chemistry; Cell biology; Cytokine; Interleukin; Medicine; Biology; Antibody","score_opus":0.013867831947297888,"score_gpt":0.3156228466059725,"score_spread":0.3017550146586746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413772343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489886,0.0021044347,0.0010837372,0.000089474765,0.00003081003,0.000028533479,0.0002469194,0.000088952715,0.0014281545],"genre_scores_gemma":[0.9964646,0.0005273584,0.0008520543,0.000053395113,0.000011481157,0.000045489396,0.00028696875,0.000009198206,0.0017493466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998443,0.000035988105,0.0000143279185,0.000025998403,0.000032867505,0.00004646626],"domain_scores_gemma":[0.99993145,0.000011114342,0.000017365763,0.000009466179,0.0000085080765,0.000022059918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009915774,0.0002948739,0.00022401595,0.0001843673,0.0000839548,0.0002755501,0.00015832447,0.0001970745,0.0017073262],"category_scores_gemma":[0.00009489426,0.00007925427,0.00016992424,0.00011009933,0.00019029787,0.00015767243,0.00015377325,0.000410516,0.00034545717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003475378,0.00012094527,0.0001729079,0.000044692388,0.000006807263,0.000032327436,0.000010099011,0.0000961848,0.99733114,0.0000615187,0.000076807504,0.001699081],"study_design_scores_gemma":[0.00008584269,0.0010221245,0.0020251612,0.000005135807,0.000021087273,0.00016694193,0.000020705082,0.0007359539,0.9927632,0.000062782834,0.003088613,0.000002492944],"about_ca_topic_score_codex":0.00031188084,"about_ca_topic_score_gemma":0.0003980106,"teacher_disagreement_score":0.0017073262,"about_ca_system_score_codex":0.00024087446,"about_ca_system_score_gemma":0.00020899904,"threshold_uncertainty_score":0.0057115555},"labels":[],"label_agreement":null},{"id":"W7141300528","doi":"10.1093/immadv/ltaf031","title":"Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study","year":2025,"lang":"en","type":"article","venue":"Immunotherapy Advances","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Nivolumab; Atezolizumab; Pembrolizumab; Hazard ratio; Ipilimumab; Overall survival; Proportional hazards model; Baseline (sea); Biomarker","score_opus":0.0046702480945134735,"score_gpt":0.2520719266116027,"score_spread":0.24740167851708925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7141300528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900264,0.00016768828,0.00008095138,0.000015984846,0.0000061369715,0.000023147926,0.0005607456,0.0000022569209,0.0001403806],"genre_scores_gemma":[0.9991246,0.000055280754,0.000052725372,0.000019095938,0.000012751974,0.000021555343,0.0006354244,0.0000024632086,0.000076125885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894744,0.00025938507,0.00010475588,0.00038277678,0.00015181744,0.00015377792],"domain_scores_gemma":[0.9984211,0.00021228932,0.0005765011,0.000273765,0.0001909894,0.00032533196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001277186,0.00047680893,0.000948874,0.00058009196,0.0005437015,0.0010778111,0.0005883424,0.0005890839,0.0013898754],"category_scores_gemma":[0.001980973,0.0004978359,0.0013170551,0.0012893996,0.0003730235,0.000760542,0.0007850743,0.000983775,0.00035505998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007193048,0.000054688247,0.99792624,0.000014689483,0.00023109834,0.00007028769,0.000057511927,0.000054081942,0.00024159245,0.000009685019,0.000114659204,0.000506167],"study_design_scores_gemma":[0.000059630085,0.00037602038,0.9986381,0.000007326352,0.000121493256,0.0001844709,0.00011927479,0.00026685942,0.000041071347,0.000015568781,0.00016126862,0.0000089464875],"about_ca_topic_score_codex":0.004250044,"about_ca_topic_score_gemma":0.0044831014,"teacher_disagreement_score":0.004250044,"about_ca_system_score_codex":0.0004972962,"about_ca_system_score_gemma":0.0004283152,"threshold_uncertainty_score":0.008450627},"labels":[],"label_agreement":null},{"id":"W7147334668","doi":"10.1093/immadv/ltaf038","title":"Chimeric CD3ζ chains containing CD28 signalling motifs enhance antigen-specific IL-2 production and expansion of human TCR-engineered T cells <i>in vitro</i>","year":2025,"lang":"en","type":"article","venue":"Immunotherapy Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"CD28; T-cell receptor; Cytotoxic T cell; Chimeric antigen receptor; Antigen; Effector; Streptamer; Signal transduction; Jurkat cells","score_opus":0.015110604342451496,"score_gpt":0.30191830494043137,"score_spread":0.2868077005979799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7147334668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442697,0.00052740244,0.0032579578,0.00003915181,0.000026510017,0.000044937802,0.00022270673,0.00007409592,0.0013802431],"genre_scores_gemma":[0.99527115,0.00021819428,0.0024810997,0.000036673242,0.000012380236,0.000028416038,0.00042669591,0.000020164309,0.0015052534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981517,0.000034758785,0.000017410603,0.000033994354,0.000043431453,0.000055313478],"domain_scores_gemma":[0.99990976,0.00003071237,0.000015140077,0.000010807946,0.000011001496,0.000022550454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017707965,0.00047937673,0.00018704044,0.00013441374,0.000064597814,0.00029573173,0.00011660392,0.0002446775,0.0011351812],"category_scores_gemma":[0.00010052383,0.000108610075,0.00021708423,0.00009243127,0.00011761699,0.000111030706,0.00016107652,0.0005401447,0.0005036122],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008971818,0.000032259388,0.000059328264,0.000010247277,0.0000017859426,0.000022664133,0.000007528427,0.000100221674,0.9991917,0.00001931163,0.000021380532,0.00044381985],"study_design_scores_gemma":[0.000021285332,0.00030141696,0.00073719275,0.0000028430989,0.000008858367,0.00008821615,0.0000071308145,0.0012928614,0.99677294,0.000012115103,0.00075336423,0.0000017620001],"about_ca_topic_score_codex":0.00031051962,"about_ca_topic_score_gemma":0.00031786587,"teacher_disagreement_score":0.0011351812,"about_ca_system_score_codex":0.00017410617,"about_ca_system_score_gemma":0.00009407357,"threshold_uncertainty_score":0.0037975311},"labels":[],"label_agreement":null},{"id":"W7163193919","doi":"10.1093/immadv/ltag010","title":"NLRC5 expression within tumor cells is critical to activate adaptive and innate antitumor immune responses","year":2025,"lang":"en","type":"article","venue":"Immunotherapy Advances","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Downregulation and upregulation; Immune system; Melanoma; Tumor microenvironment; Antigen presentation; Autophagy; Antigen; Acquired immune system","score_opus":0.01005255377483979,"score_gpt":0.2931361700015136,"score_spread":0.28308361622667383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7163193919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922563,0.0019706166,0.0031948965,0.000090228496,0.000022980645,0.000020807705,0.00090323424,0.00009943126,0.0014415866],"genre_scores_gemma":[0.9955297,0.00027864217,0.0013282096,0.000033479446,0.00000543991,0.000014682282,0.0012761261,0.00001531721,0.001518356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996965,0.000035225352,0.000029372692,0.000077765006,0.00008707424,0.00007410446],"domain_scores_gemma":[0.99985754,0.000008922405,0.00006561246,0.000017417236,0.000016138818,0.000034443732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010233332,0.00029273442,0.00017668415,0.00014576275,0.00012418603,0.000297888,0.00011956767,0.00025548096,0.002085727],"category_scores_gemma":[0.000108940425,0.00009002138,0.00028902167,0.00011466485,0.00014997191,0.00018861625,0.00016692776,0.00030281543,0.0006074897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051767263,0.0000051417805,0.00041684287,0.000027151811,0.0000027961346,0.00003108808,0.000004955074,0.000028136006,0.9989429,0.00003380593,0.00003150972,0.00042382957],"study_design_scores_gemma":[0.0000149971265,0.00015891362,0.027142992,0.000015044583,0.000022598082,0.0007374456,0.000045498306,0.001014497,0.96572876,0.000050701878,0.0050635505,0.0000049839637],"about_ca_topic_score_codex":0.0006533643,"about_ca_topic_score_gemma":0.00060847535,"teacher_disagreement_score":0.002085727,"about_ca_system_score_codex":0.0004797813,"about_ca_system_score_gemma":0.0001689051,"threshold_uncertainty_score":0.006977439},"labels":[],"label_agreement":null}]}